White House Drafted NIH Grant Oversight Panel
The administration is proposing new rules to terminate federal grants without notice.
Updated on Sept. 21, 2026 in COVID-19
Live Poll
Should the White House have the authority to veto NIH research grants based on political criteria?
The White House is drafting an executive order to create a panel that would review NIH research grants to ensure they align with the President's agenda. Additionally, the Office of Management and Budget has proposed a policy that would allow the President to suspend or terminate federal grants at any time without prior notice.
Why it matters
The administration intends to align scientific research projects with the President's political priorities. Critics argue these moves represent a significant shift in federal research oversight and funding authority.
The administration has proposed a 40% cut to total NIH funding. Furthermore, the President has already reduced the total amount of grant money awarded to research projects during his second term.
The players
Tammy Baldwin
She is a U.S. Senator representing Wisconsin who has actively opposed the proposed changes to federal grant oversight.
Office of Management and Budget
This federal agency is responsible for assisting the President in overseeing the implementation of his vision across the executive branch.
National Institutes of Health
This is the primary federal agency responsible for conducting and supporting medical and public health research in the United States.
The details
The proposed executive order would establish a panel chosen by the White House to veto research that does not conform to the President's policy objectives. These actions reflect a broader effort to consolidate control over federal research grants and their associated expenditures.
Timeline
In July 2026, Senator Tammy Baldwin expressed opposition to the proposed OMB rule.
On September 21, 2026, Senator Baldwin released a statement regarding the executive order.
The Big Picture
The proposed executive order marks a significant departure from the traditional independence established by the 1944 Public Health Service Act. It shifts grant control toward direct political oversight rather than established peer-review processes.
These policy changes could lead to significant disruptions in ongoing medical studies if research grants are suspended without notice. Taxpayers and patients may see a reduction in the scope of federally funded medical advancements if the 40% funding cut is implemented.
The takeaway
The move toward political oversight of scientific grants creates uncertainty for ongoing research initiatives across the country. Researchers and institutions should prepare for potential funding instability as the administration moves to tighten control over federal expenditures.
Further reading
For more on the national response to health crises and research, see COVID-19.
Live Poll
Should the White House have the authority to veto NIH research grants based on political criteria?
